Peter Turvey
Corporate Secretary en ZENYTH THERAPEUTICS LIMITED .
Perfil
Peter R.
Turvey currently works at Cell Therapies Pty Ltd., as Non-Executive Director, AusBiotech Ltd., as Director from 2012, Agriculture Victoria Services Pty Ltd., as Director from 2012, Phytogene Pty Ltd., as Director, CSL Innovation Pty Ltd., as Secretary, Australian Institute of Co. Directors, as Member, and Foursight Associates Pty Ltd., as Principal from 2012.
Mr. Turvey also formerly worked at Starpharma Holdings Ltd., as Deputy Chairman from 2019 to 2021, ImmVirX Pty Ltd., as Chairman, Viralytics Pty Ltd., as Non-Executive Director from 2014 to 2018, Anteris Technologies Ltd., as Independent Non-Executive Director from 2012 to 2016, and CSL Ltd., as Secretary, EVP-Licensing & Group General Counsel from 1998 to 2011.
Mr. Turvey received his undergraduate degree and graduate degree from Australian National University.
Cargos activos de Peter Turvey
| Empresas | Cargo | Inicio |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Corporate Secretary | - |
Foursight Associates Pty Ltd.
 Foursight Associates Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Foursight Associates Pty Ltd. provides an advisory service in science, technology, research and development. The company was founded in 1996 and is headquartered in Melbourne, Australia. | Corporate Officer/Principal | 18/05/2012 |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Director/Board Member | 17/09/2012 |
| Agriculture Victoria Services Pty Ltd. | Director/Board Member | 01/07/2012 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
| Cell Therapies Pty Ltd. | Director/Board Member | - |
| Phytogene Pty Ltd. | Director/Board Member | - |
Antiguos cargos conocidos de Peter Turvey.
| Empresas | Cargo | Fin |
|---|---|---|
ImmVirX Pty Ltd.
 ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Chairman | 04/08/2021 |
| STARPHARMA HOLDINGS LIMITED | Director/Board Member | 29/07/2021 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formación de Peter Turvey.
| Australian National University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CSL LIMITED | Health Technology |
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| ANTERIS TECHNOLOGIES LTD | Health Technology |
| Empresas privadas | 9 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
| Cell Therapies Pty Ltd. | |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services AusBiotech Ltd. operates as an Australian biotechnology membership company. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded by Liz Dallimore. Lorraine Chiroiu has been the CEO of the company since 2008. | Commercial Services |
| Agriculture Victoria Services Pty Ltd. | |
Foursight Associates Pty Ltd.
Foursight Associates Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Foursight Associates Pty Ltd. provides an advisory service in science, technology, research and development. The company was founded in 1996 and is headquartered in Melbourne, Australia. | Commercial Services |
ImmVirX Pty Ltd.
ImmVirX Pty Ltd. Miscellaneous Commercial ServicesCommercial Services ImmVirX Pty Ltd. develops oncotic viral immunotherapy. The Australian company was founded in 2019 by Malcolm L. McColl and Darren Shafren. Malcolm L. McColl has been the CEO since 2019. | Commercial Services |
| Phytogene Pty Ltd. |
- Bolsa de valores
- Insiders
- Peter Turvey
